Literature DB >> 25737417

Epidemiology and risk factors for exocrine pancreatic cancer in a Northern African population.

Feriel Sellam1, Noria Harir, Méghit B Khaled, Nesrine M Mrabent, Rachida Salah, Mustapha Diaf.   

Abstract

BACKGROUND: The etiology of pancreatic cancer remains largely unknown. Although epidemiological studies have reported that many environmental factors may contribute to the development of pancreatic cancer, only age and cigarette smoking have been established as consistent risk factors for the disease.
OBJECTIVE: Studying the biological clinical and histological features of patients with pancreatic cancer in order to assess the possible risk factors for pancreatic cancer in a North African population.
METHODS: An epidemiological retrospective descriptive study has been performed at the level of surgery department of the university hospital of Sidi bel Abbes region, western Algeria, from 2007 to 2013.
RESULTS: A total of 87 patients were diagnosed with cancer of the pancreas (55 males and 32 females) with a mean age of 63.1 years, ranging from 16 to 96 years old, and a sex ratio of 1.71. In 92 % of cases, pancreatic tumors were located at the head of the pancreas; the most predominant histological type was the adenocarcinoma; cigarette smokers represented the rate of 24.3 % and alcoholics 13.5 %. The most recorded disease among patients medical history was diabetes mellitus (25.28 %). About 35.63 % was the prominent rate of patients who underwent cholecystectomy and was diagnosed with pancreatic cancer after an average duration of 5.23 years. Our patients were mostly diagnosed with cancer at M1 and T3 stages.
CONCLUSION: According to our results, cholecystectomy could possibly be a risk factor for pancreatic cancer in Algerian population.

Entities:  

Mesh:

Year:  2015        PMID: 25737417     DOI: 10.1007/s12029-015-9693-4

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  23 in total

1.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

2.  Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

Authors:  D S Weinberg; B Ruggeri; M T Barber; S Biswas; S Miknyocki; S A Waldman
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus.

Authors:  Xiong Ding; Chang-You Lu; Ying Mei; Chang-An Liu; Yu-Jun Shi
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-05

4.  Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients.

Authors:  T L Peeters; G Vantrappen; J Janssens
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

5.  Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion.

Authors:  N Rivard; D Guan; D Maouyo; G Grondin; F L Bérubé; J Morisset
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

6.  Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States.

Authors:  Melvin K Lau; Jessica A Davila; Yasser H Shaib
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

Review 7.  Epidemiology of pancreatic cancer.

Authors:  D S Michaud
Journal:  Minerva Chir       Date:  2004-04       Impact factor: 1.000

8.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

9.  Does cholecystectomy prior to the diagnosis of pancreatic cancer affect outcome?

Authors:  Stephen H Gray; Mary T Hawn; Meredith L Kilgore; Huifeng Yun; John D Christein
Journal:  Am Surg       Date:  2008-07       Impact factor: 0.688

10.  Delay of diagnosis in pancreatic cancer due to suspected symptomatic cholelithiasis.

Authors:  B M Ghadimi; O Horstmann; K Jacobsen; J Feth; H Becker
Journal:  Scand J Gastroenterol       Date:  2002-12       Impact factor: 2.423

View more
  2 in total

Review 1.  Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.

Authors:  Yolanda Rodríguez Gil; Paula Jiménez Sánchez; Raúl Muñoz Velasco; Ana García García; Víctor Javier Sánchez-Arévalo Lobo
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

2.  Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.

Authors:  Sijie Hao; Lie Yao; Jiaxin Huang; Hang He; Feng Yang; Yang Di; Chen Jin; Deliang Fu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.